• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

4-Chloro-6-(cyclopropylmethoxy)pyrimidine (CAS No. 1249603-83-5): A Versatile Building Block in Modern Pharmaceutical Chemistry

In the rapidly evolving field of pharmaceutical chemistry, 4-Chloro-6-(cyclopropylmethoxy)pyrimidine (CAS No. 1249603-83-5) has emerged as a crucial intermediate compound with significant applications in drug discovery and development. This heterocyclic compound, featuring both chloro and cyclopropylmethoxy functional groups, offers unique reactivity patterns that make it particularly valuable for medicinal chemistry applications.

The molecular structure of 4-Chloro-6-(cyclopropylmethoxy)pyrimidine combines the electron-withdrawing effect of the chlorine atom at position 4 with the steric influence of the cyclopropylmethoxy group at position 6. This combination creates a versatile platform for further chemical modifications, especially in the synthesis of kinase inhibitors and other targeted therapies. Recent literature highlights its growing importance in the development of JAK inhibitors and BTK inhibitors, which are currently hot topics in autoimmune disease and oncology research.

From a synthetic chemistry perspective, 4-Chloro-6-(cyclopropylmethoxy)pyrimidine demonstrates excellent stability under various reaction conditions while maintaining sufficient reactivity for nucleophilic aromatic substitution. This balance makes it particularly useful for parallel synthesis approaches and combinatorial chemistry, addressing the pharmaceutical industry's need for efficient lead optimization strategies. The cyclopropyl moiety in particular has gained attention in drug design due to its ability to modulate metabolic stability and improve pharmacokinetic properties.

The commercial availability of 4-Chloro-6-(cyclopropylmethoxy)pyrimidine (CAS 1249603-83-5) has significantly increased in recent years, reflecting its growing importance in medicinal chemistry. Current market analysis shows steady demand from both academic research institutions and pharmaceutical companies, particularly those focusing on small molecule drug discovery and fragment-based drug design. Suppliers typically offer this compound with purity levels exceeding 98%, suitable for most research applications.

Quality control aspects of 4-Chloro-6-(cyclopropylmethoxy)pyrimidine production emphasize rigorous analytical characterization. Standard quality specifications include HPLC purity verification, NMR confirmation of structure, and careful monitoring of residual solvents. These quality measures ensure the compound's reliability in sensitive pharmaceutical applications where reproducibility is critical.

Environmental and safety considerations for handling 4-Chloro-6-(cyclopropylmethoxy)pyrimidine follow standard laboratory protocols for organic compounds. While not classified as highly hazardous, proper personal protective equipment including gloves and safety glasses is recommended during handling. Storage typically requires protection from moisture at room temperature, with many suppliers offering stabilized formulations for extended shelf life.

The future outlook for 4-Chloro-6-(cyclopropylmethoxy)pyrimidine appears promising, with several patent applications citing its use in novel therapeutic agents. Its structural features align well with current trends in drug discovery, particularly the growing emphasis on three-dimensional molecular complexity in lead compounds. As pharmaceutical research continues to explore more sophisticated targets, the demand for specialized building blocks like this pyrimidine derivative is expected to grow accordingly.

For researchers considering 4-Chloro-6-(cyclopropylmethoxy)pyrimidine (CAS 1249603-83-5) for their projects, several synthetic routes have been published in recent literature. The most common approaches involve sequential functionalization of pyrimidine precursors, with careful control of reaction conditions to ensure regioselectivity. Many of these methods have been optimized for scalability, addressing the needs of both medicinal chemistry and process development teams.

In conclusion, 4-Chloro-6-(cyclopropylmethoxy)pyrimidine represents an important tool in modern drug discovery, combining useful reactivity with structural features that align with current medicinal chemistry priorities. Its commercial availability and well-characterized properties make it accessible to researchers across the pharmaceutical development spectrum, from early hit identification to lead optimization stages. As the field continues to evolve, this compound is likely to maintain its relevance in the design of next-generation therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)